mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain.

Neurosci Res

Division of Molecular Neurobiology, Brain Research Institute, Niigata University, 1-757 Asahimachi, Chuo-ku, Niigata 951-8585, Japan.

Published: April 2011

Cereblon is implicated in mild mental retardation and proved to bind to a teratogenic hypnotic, thalidomide. Here, we determined cereblon mRNA distributions in adult mouse brain. Almost all neurons expressed cereblon mRNA with various intensities whereas the signals in astrocytes and oligodendrocytes were modest or negligible. Intense mRNA signals were found in the hippocampus and cerebellum, especially in hippocampal pyramidal cells and Purkinje cells. Higher levels of cereblon mRNA were also detected in serotonergic and noradrenergic neurons in raphe nuclei and locus ceruleus, respectively. These observations indicate novel biological roles of cereblon in neuronal physiology and thalidomide pharmacology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neures.2010.12.019DOI Listing

Publication Analysis

Top Keywords

cereblon mrna
12
adult mouse
8
mouse brain
8
cereblon
6
mrna
5
mrna distribution
4
distribution thalidomide
4
thalidomide binding
4
binding protein
4
protein cereblon
4

Similar Publications

Potential of GSPT1 as a novel target for glioblastoma therapy.

Cell Death Dis

August 2024

Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, Japan.

Article Synopsis
  • * Research indicates that reducing GSPT1, a protein involved in cell cycle regulation, can slow down glioblastoma cell growth and enhance survival in mice treated with the drug CC-885.
  • * Although GSPT1 is essential for the proliferation of glioblastoma cells, its levels do not appear to correlate with patient survival, suggesting it may serve as a promising therapeutic target rather than an indicator of tumor malignancy.
View Article and Find Full Text PDF

The Relationship Between the Expression of CRBN in Peripheral Blood and the Severity and Prognosis of Adult Sepsis.

Int J Gen Med

November 2023

Department of Critical Care Medicine, Ganzhou People's Hospital, Ganzhou, Jiangxi Province, 341000, People's Republic of China.

Objective: To investigate the correlation between the expression of cereblon (CRBN) protein in peripheral blood and the severity and prognosis of sepsis.

Methods: A total of 130 patients with sepsis admitted to our hospital were selected as the observation subjects (sepsis group). The patients were divided into mild group, moderate group and severe group according to their conditions.

View Article and Find Full Text PDF

The retinoblastoma protein (Rb) is encoded by the RB1 tumor suppressor gene. Inactivation of RB1 by inherited or somatic mutation occurs in retinoblastoma and various other types of tumors. A significant fraction (25.

View Article and Find Full Text PDF

Cereblon influences the timing of muscle differentiation in tadpoles.

Proc Natl Acad Sci U S A

October 2023

Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544.

Thalidomide has a dark history as a teratogen, but in recent years, its derivates have been shown to function as potent chemotherapeutic agents. These drugs bind cereblon (CRBN), the substrate receptor of an E3 ubiquitin ligase complex, and modify its degradation targets. Despite these insights, remarkably little is known about the normal function of cereblon in development.

View Article and Find Full Text PDF

Discovery of Ibrutinib-based BTK PROTACs with in vivo anti-inflammatory efficacy by inhibiting NF-κB activation.

Eur J Med Chem

November 2023

Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. Electronic address:

As a critical upstream regulator of nuclear factor-κB (NF-κB) activation, Bruton's tyrosine kinase (BTK) has been identified to be an effective therapeutic target for the treatment of acute or chronic inflammatory diseases. Herein, we describe the design, synthesis and structure-activity-relationship analysis of a novel series of Ibrutinib-based BTK PROTACs by recruiting Cereblon (CRBN) ligase. Among them, compound 15 was identified as the most potent degrader with a DC of 3.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!